Top Intraocular Lens Companies in 2025 – Market Leaders & Trends
12 May, 2025

Overview of the Global Intraocular Lens Market

An intraocular lens (IOL) is a synthetic lens placed inside the eye to substitute for the natural lens of the eye when it is extracted in cataract surgery or to fix refractive defects. IOLs are usually constructed of biocompatible materials like silicone or acrylic and are intended to be permanent inside the eye. The lenses restore vision by refracting light appropriately onto the retina, thus improving clarity and diminishing reliance on eyeglasses or contact lenses.

Worldwide, IOLs are utilized most frequently to manage cataracts—one of the most prevalent forms of blindness—primarily in elderly groups. Besides traditional monofocal IOLs, newer models such as multifocal, toric, and accommodating lenses provide better vision at different distances or eliminate astigmatism.

The growing aging population, technological innovations in ophthalmic devices, and increasing eye health awareness are fueling the global demand for IOLs. They are an integral part of contemporary vision correction and eye care globally. The intraocular lens market is expected to reach US$ 4.46 billion in 2024 and is expected to expand to US$ 7.16 billion by 2033, registering a compound annual growth rate (CAGR) of 5.40% during 2025-2033.

North America intraocular lens market Overview

An intraocular lens (IOL) is an artificial lens inserted at cataract surgery to replace the natural lens in the eye, allowing for clear vision by concentrating light on the retina. Constructed from silicone or acrylic, IOLs correct visual problems such as astigmatism, nearsightedness, and farsightedness. Types such as monofocal, multifocal, toric, and extended depth-of-focus lenses enhance quality of life after surgery. The North American IOL market is expanding because of the graying population, increasing cataract and age-related visual problems, and the prevalence of diabetes. Technological advancements in surgical methods and premium lens solutions, including multifocal and toric lenses, are also driving market demand. Moreover, government and NGO initiatives to expand access to cataract surgery also drive growth. The North America intraocular lens market is expected to expand from US$ 1.53 billion in 2024 to US$ 2.38 billion by 2033, growing at a compound annual growth rate (CAGR) of 5.00% during 2025-2033.

Discover key trends, growth opportunities, and major challenges shaping the Global intraocular lens Industry in Renub Research’s latest in-depth market report. Download your free sample now

Top Intraocular Lens Companies in 2025 – Market Leaders & Trend

Alcon Inc.

Founding: 1945

Headquarters: Switzerland

Website: www.alcon.com

Alcon Inc. is a pioneering company in ophthalmic device development and manufacturing. Its portfolio consists of contact lenses and surgical solutions, including implantable devices, consumables, and surgical instruments. These products are applied in the treatment of various eye disorders, such as cataracts, glaucoma, retinal disorders, and refractive defects. Alcon performs clinical studies to evaluate the safety and efficacy of its products in the prevention and treatment of blindness and other eye diseases. Alcon partners with institutions, medical innovators, research consultants, and academic leaders to create new products. Alcon has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific region.

Bausch Health Companies Inc.

Year of establishment: 1959

Headquarter: Canada

Website: www.bauschhealth.com

Bausch Health Companies Inc. develops, produces, and markets medical devices, over-the-counter (OTC) medications, and pharmaceutical products. It has a wide range of therapeutic areas such as dermatology, gastroenterology, eye health, neurology, aesthetics, dentistry, and consumer health. The company offers both generic and branded generic products. Bausch Health has administrative, research, marketing, distribution, and warehousing facilities across the world. Its products are distributed in areas like the US, Canada, Africa, the Middle East, Australia, Latin America, and Europe. The company also has manufacturing facilities in the US, Brazil, Colombia, Germany, and Canada, among others.

Hoya Corporation

Founding: 1941

Head Office: Japan

Website: www.hoya.com

Hoya Corp is a med-tech firm that deals in precision devices and instruments driven by cutting-edge optics technologies. Its principal products are eyeglasses, contact lenses, laparoscopic surgical devices, medical endoscopes, intraocular lenses, orthopedic implants, airway scopes, semiconductor and LCD photomasks, and hard disk drive glass disks. Hoya also manufactures imaging products such as optical lenses, camera lens modules, plastic lenses, lasers, and ultraviolet light sources. Hoya also provides IT solutions. Hoya's major technologies include glass formation, molding, polishing, thin film, lithography, optics design, and optomechatronics. The firm is present in markets such as Asia-Pacific, the Americas, and Europe.

Johnson & Johnson

Founding: 1886

Head Office: United States of America

Website: www.jnj.com

Johnson & Johnson (J&J) is an international healthcare corporation engaged in researching, developing, manufacturing, and selling innovative pharmaceuticals and medical technologies. J&J distributes its products to wholesalers, retailers, hospitals, and healthcare professionals. The company operates through its subsidiaries and sells pharmaceutical products aimed at immune disorders, cancer, neurological conditions, infectious diseases, and cardiovascular and metabolic diseases. It also supplies medical devices applied in cardiovascular, orthopedic, neurovascular care, general surgery, and vision care. With production plants in the US, Europe, Asia-Pacific, Africa, the Western Hemisphere (outside of the US), and Latin America, J&J is well represented internationally.

STAAR Surgical Company

Formation: 1982

Head Office: United States of America

Website: www.staar.com

STAAR Surgical Co. is an ophthalmic surgical products manufacturer that deals specifically in implantable lenses. STAAR develops, manufactures, and sells intraocular lenses (IOLs) and implantable collamer lenses (ICLs), such as EVO Visian ICL, EVO+ Visian ICL, Visian ICL, Collamer IOLs, and Preloaded IOLs. STAAR's IOLs are mainly intended for cataract patients, whereas its ICLs are used to treat myopia, astigmatism, hyperopia, and astigmatism with an increased optic. STAAR sells its ICLs with CentraFLOW technology under the brand names of EVO and EVO+. STAAR markets its ophthalmic products through a combination of in-house sales persons and independent distributors. The business is conducted in the US, Japan, Germany, Singapore, Canada, Spain, and Switzerland.

Carl Zeiss Meditec AG (Carl-Zeiss-Stiftung)

Formed: 2002

Head office: Germany

Website: www.zeiss.com

Carl Zeiss AG, owned by Carl Zeiss Stiftung AG, is one of the medical technology leaders involved in the development and commercialization of optical and optoelectronic products. The company's vast portfolio comprises lithography optics, microscopes, measuring technology, photomask systems, diagnostic and therapeutic products for ophthalmology, eyeglass lenses, camera and cine lenses, and binoculars. Moreover, Carl Zeiss provides planetarium software for its diverse range of projection devices installed at sky theaters, star theaters, and universe theaters. The company caters to various industries like semiconductor, automotive, mechanical engineering, biomedical research, and medical technology. Carl Zeiss has operations in geographies such as EMEA (Europe, Middle East, Africa), the Americas, and APAC (Asia-Pacific).

Novartis AG

Founding: 1996

Head office: Switzerland

Website: www.novartis.com

Novartis AG is a multinational pharma company focused on research, development, manufacture, marketing, and sale of innovative medicines. The company distributes a diversified range of products within therapeutic areas of cardiovascular, renal and metabolic disease, immunology, ophthalmology, respiratory disease, global health, neuroscience, and oncology. Novartis distributes its products across numerous channels, including pharmacists, healthcare systems, government institutions, physicians, hospitals, and insurance groups, under established brands like Entresto, Cosentyx, Kesimpta, Kisqali, and Tasigna. Novartis has manufacturing sites in nations such as the US, Switzerland, Austria, Slovenia, China, France, and Italy, distributing to markets across the globe.